Power law IVIVC: An application of fractional kinetics for drug release and absorption

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 2, 2010, Pages 299-304

  Kytariolos, John ^a   Dokoumetzidis, Aristides ^a   Macheras, Panos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Drug release; Fractional kinetics; IVIVC; Power law

Indexed keywords

ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; LINEAR SYSTEM; METHODOLOGY; NONLINEAR SYSTEM; POWER ANALYSIS; PRIORITY JOURNAL;

KINETICS; PHARMACOKINETICS;

EID: 77955844453     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.06.015     Document Type: Article

References (71)

1. Al-Behaisi S., Antal I., Morovján G., Szúnyog J., Drabant S., Marton S., Klebovich I. In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers. Eur. J. Pharm. Sci. 2002, 15:157-162.
2. AlKhatib H., Aiedeh K., Bustanji Y., Hamed S., Mohammad M., AlKhalidi B., Najjar S. Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release. Eur. J. Pharm. Biopharm. 2008, 70:804-812.
3. Bunde A., Havlin S., Nossal R., Stanley H., Weiss G. On controlled diffusion limited drug release from a leaky matrix. J. Chem. Phys. 1985, 83:5909-5913.
4. Cedillo-Ramírez E., Villafuerte-Robles L., Hernandez-Leon A. Effect of added Pharmatose DCL11 on the sustained-release of metronidazole from Methocel K4M and Carbopol 971P NF floating matrices. Drug Dev. Ind. Pharm. 2006, 32:955-965.
5. Corrigan O., Devlin Y., Butler J. Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation. Int. J. Pharm. 2003, 254:147-154.
6. Cutler D. Numerical deconvolution by least squares: use of polynomials to represent the input function. J. Pharmacokinet. Pharmacodyn. 1978, 6:243-263.
7. Cutler D. Numerical deconvolution by least squares: use of prescribed input functions. J. Pharmacokinet. Pharmacodyn. 1978, 6:227-241.
8. D'Arcy D., Corrigan O., Healy A. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability. J. Pharm. Pharmacol. 2005, 57:1243-1250.
9. D'Arcy D., Corrigan O., Healy A. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics - dissolution rate implications. Eur. J. Pharm. Sci. 2006, 27:259-267.
10. Dokoumetzidis A., Kosmidis K., Argyrakis P., Macheras P. Modeling and Monte Carlo simulations in oral drug absorption. Basic Clin. Pharmacol. Toxicol. 2005, 96:200-205.
11. Dokoumetzidis A., Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharm. 2006, 321:1-11.
12. Dokoumetzidis A., Macheras P. IVIVC of controlled release formulations: physiological-dynamical reasons for their failure. J. Control. Release 2008, 129:76-78.
13. Dokoumetzidis A., Macheras P. Fractional kinetics in drug absorption and disposition processes. J. Pharmacokinet. Pharmacodyn. 2009, 36:165-178.
14. Dokoumetzidis A., Magin R., Macheras P. A commentary on fractionalization of multi-compartmental models. J. Pharmacokinet. Pharmacodyn. 2010, 37:203-207.
15. Dressman J., Amidon G., Reppas C., Shah V. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 1998, 15:11-22.
16. Dressman J., Vertzoni M., Goumas K., Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv. Drug Deliv. Rev. 2007, 59:591-602.
17. Dressman J.B., Fleisher D. Mixing-tank model for predicting dissolution rate control or oral absorption. J. Pharm. Sci. 1986, 75:109-116.
18. Dunne A., O'Hara T., Devane J. Level A in vivo-in vitro correlation: nonlinear models and statistical methodology. J. Pharm. Sci. 1997, 86:1245-1249.
19. Dunne A., O'Hara T., Devane J. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption. Stat. Med. 1999, 18:1865-1876.
20. Dutta S., Qiu Y., Samara E., Cao G., Granneman G. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a level A in vitro-in vivo correlation (IVIVC). J. Pharm. Sci. 2005, 94:1949-1956.
21. Eddington N., Marroum P., Uppoor R., Hussain A., Augsburger L. Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation. Pharm. Res. 1998, 15:466-473.
22. Emami J. In vitro-in vivo correlation: from theory to applications. J. Pharm. Pharm. Sci. 2006, 31-52.
23. FDA Guidance Extended Release Oral Dosage Forms: Development, Evaluation and Application of an In vitro/In vivo Correlation 1997, US Food and Drug Administration Center for Drug Evaluation and Research.
24. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50:874-875.
25. Hilfer R. Fractional Calculus in Physics 2000, World Scientific, Singapore.
26. Humbert H., Cabiac M., Bosshardt H. In vitro-in vivo correlation of a modified-release oral form of ketotifen: in vitro dissolution rate specification. J. Pharm. Sci. 1994, 83:131-1131.
27. Jiang X., Xu M. The fractional finite Hankel transform and its applications in fractal space. J. Phys. A: Math. Theor. 2009, 42:385201.
28. Kalampokis A., Argyrakis P., Macheras P. Heterogeneous tube model for the study of small intestinal transit flow. Pharm. Res. 1999, 16:87-91.
29. Kalampokis A., Argyrakis P., Macheras P. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts. Pharm. Res. 1999, 16:1764-1769.
30. Kosmidis K., Rinaki E., Argyrakis P., Macheras P. Analysis of case II drug transport with radial and axial release from cylinders. Int. J. Pharm. 2003, 254:183-188.
31. Lake O., Olling M., Barends D. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur. J. Pharm. Biopharm. 1999, 48:13-19.
32. Li X., Xu M., Jiang X. Homotopy perturbation method to time-fractional diffusion equation with a moving boundary condition. Appl. Math. Comput. 2009, 208:434-439.
33. Li X., Xu M., Wang S. Analytical solutions to the moving boundary problems with space time-fractional derivatives in drug release devices. J. Phys. A: Math. Theor. 2007, 40:12131-12141.
34. Macheras P., Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharm. Res. 2000, 17:108-112.
35. Macheras P., Iliadis A. Modeling in Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics: Homogeneous and Heterogeneous Approaches 2006, Springer Verlag.
36. Macheras P., Koupparis M., Antimisiaris S. An in vitro model for exploring CR theophylline-milk fat interactions. Int. J. Pharm. 1989, 54:123-130.
37. Macheras P., Koupparis M., Apostolelli E. Dissolution of 4 controlled-release theophylline formulation in milk. Int. J. Pharm. 1987, 36:73-79.
38. Magin R. Fractional calculus in bioengineering, part 1-3. Crit. Rev. Biomed. Eng. 2004, 32:1-378.
39. Magin R., Abdullah O., Baleanu D., Zhou X. Anomalous diffusion expressed through fractional order differential operators in the Bloch-Torrey equation. J. Magn. Reson. 2007, 190:255-270.
40. Mahayni H., Rekhi G., Uppoor R., Marroum P., Hussain A., Augsburger L., Eddington N. Evaluation of " External" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metroprolol tartrate. J. Pharm. Sci. 2000, 89:1354-1361.
41. Mandal U., Ray K., Gowda V., Ghosh A., Pal T. In-vitro and in-vivo correlation for two gliclazide extended-release tablets. J. Pharm. Pharmacol. 2007, 59:971-976.
42. Mendell-Harary J., Dowell J., Bigora S., Piscitelli D., Butler J., Farrell C., Devane J., Young D. Nonlinear in vitro-in vivo correlations. Advances in Experimental Medicine and Biology 1997, vol. 423:199-215. Plenum Press, New York.
43. Metzler R., Klafter J. The random walk's guide to anomalous diffusion: a fractional dynamics approach. Phys. Rep. 2000, 339:1-77.
44. Meyer M., Straughn A., Mhatre R., Shah V., Williams R., Lesko L. Lack of in vivo/in vitro correlations for 50mg and 250mg primidone tablets. Pharm. Res. 1998, 15:1085-1089.
45. Mircioiu C., Mircioiu I., Voicu V., Miron D. Dissolution-bioequivalence non-correlations. Basic Clin. Pharmacol. Toxicol. 2005, 96:262-264.
46. Noyes A., Whitney W. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 1897, 19:930-934.
47. Oh D.M., Curl R.L., Amidon G.L. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 1993, 10:264-270.
48. Parojčić J., Ibrić S., Djurić Z., Jovanović M., Corrigan O. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. Eur. J. Pharm. Sci. 2007, 30:264-272.
49. Peppas N. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985, 60:110.
50. Pereira L. Fractal pharmacokinetics. Comput. Math. Method M. 2009, 11:161-184.
51. Polli J., Crison J., Amidon G. Novel approach to the analysis of in vitro-in vivo relationships. J. Pharm. Sci. 1996, 85:753-760.
52. Popovic J.K., Atanackovic M.T., Pilipovic A.S., Rapaic M.R., Pilipovic S., Atanackovic T.M. A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac. J. Pharmacokinet. Pharmacodyn. 2010, 37:119-134.
53. Ravishankar H., Patil P., Samel A., Petereit H., Lizio R., Iyer-Chavan J. Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept. J. Control. Release 2006, 111:65-72.
54. Rinaki E., Valsami G., Macheras P. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm. 2003, 255:199-207.
55. Ritger P., Peppas N. A simple equation for description of solute release. II: fickian and anomalous release from swellable devices. J. Control. Release 1987, 5:37-42.
56. Siepmann J., Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001, 48:139-157.
57. Sinko P., Leesman G., Amidon G. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 1991, 8:979-988.
58. Sirisuth N., Augsburger L., Eddington N. Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation. Biopharm. Drug Dispos. 2002, 23:1-8.
59. Sokolov I., Klafter J., Blumen A. Fractional kinetics. Phys. Today 2002, 55:48-54.
60. Sreenivasa Rao B., Seshasayana A., Pardha Saradhi S., Ravi Kumar N., Narayan C., Ramana Murthy K. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of rifampicin from ethylcellulose coated nonpareil beads. Int. J. Pharm. 2001, 230:1-9.
61. Takka S., Sakr A., Goldberg A. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. J. Control. Release 2003, 88:147-157.
62. USP XXIV, 2000. United States Pharmacopeial Convention, Inc., Rockville, MD, USA.
63. Varshosaz J., Ghafghazi T., Raisi A., Falamarzian M. Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. Eur. J. Pharm. Biopharm. 2000, 50:301-306.
64. Veng-Pedersen P. An algorithm and computer program for deconvolution in linear pharmacokinetics. J. Pharmacokinet. Pharmacodyn. 1980, 8:463-481.
65. Verotta D. Two constrained deconvolution methods using spline functions. J. Pharmacokinet. Pharmacodyn. 1993, 21:609-636.
66. Verotta D. Fractional compartmental models and multi-term Mittag-Leffler response functions. J. Pharmacokinet. Pharmacodyn. 2010, 37:209-215.
67. Verotta D. Fractional dynamics pharmacokinetics-pharmacodynamic models. J. Pharmacokinet. Pharmacodyn. 2010, 37:257-276.
68. Weitschies W., Kosch O., Mönnikes H., Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 2005, 57:1210-1222.
69. Wu Y., Kildsig D., Ghaly E. Effect of hydrodynamic environment on tablets dissolution rate. Pharm. Dev. Technol. 2004, 9:25-37.
70. Young D. Significance of in vitro in vivo correlation (IVIVC). International Bioequivalence Standards: A New Era 2006, 41-48. TSRL, Ann Arbor. G. Amidon, L. Lesko, K. Midha, V. Shah, J. Hilfinger (Eds.).
71. Zhou H. Pharmacokinetic strategies in deciphering atypical drug absorption profiles. J. Clin. Pharmacol. 2003, 43:211-227.